Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.53 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.53 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6894748 | 0.98 | ADRB2 (0.54) | ADRB2ADRB1ADRB3ALDH1A1MEN1 | |
| SCHEMBL10322321 | 0.94 | ADRB2 (0.50) | ADRB2ADRB1ADRB3ALDH1A1MEN1 | |
| SCHEMBL1170276 | 0.90 | ADRB2 (0.47) | ADRB2ADRB1ADRB3ALDH1A1MEN1 | |
| SCHEMBL1196568 | 0.90 | ADRB2 (0.45) | ADRB2ADRB1ADRB3ALDH1A1MEN1 | |
| SCHEMBL6141274 | 0.90 | ADRB2 (0.45) | ADRB2ADRB1ADRB3ALDH1A1MEN1 | |
| SCHEMBL812974 | 0.87 | ADRB2 (0.49) | ADRB2ADRB1ADRB3ALDH1A1MEN1 | |
| SCHEMBL20694820 | 0.86 | ADRB2 (0.55) | ADRB2ADRB1ADRB3ALDH1A1MEN1 | |
| SCHEMBL1169784 | 0.86 | ADRB2 (0.44) | ADRB2ADRB1ADRB3ALDH1A1MEN1 | |
| SCHEMBL1297781 | 0.86 | ADRB2 (0.42) | ADRB2ADRB1ADRB3ALDH1A1MEN1 | |
| SCHEMBL13898856 | 0.85 | ADRB2 (0.48) | ADRB2ADRB1ADRB3ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116023552-B | Catalyst and catalyst system for olefin polymerization | 中国石油化工股份有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-116023553-B | Catalyst component for olefin polymerization reaction, catalyst system and application | 中国石油化工股份有限公司 | 2024-09-17 | — | — | CN | claimed |
| CN-116023552-A | Catalyst and catalyst system for olefin polymerization | 中国石油化工股份有限公司 | 2023-04-28 | — | — | CN | claimed |
| CN-116023554-A | Catalyst active component, solid catalyst and catalyst system for olefin polymerization | 中国石油化工股份有限公司 | 2023-04-28 | — | — | CN | claimed |
| CN-116023553-A | Catalyst for olefin polymerization reaction, catalyst system and application | 中国石油化工股份有限公司 | 2023-04-28 | — | — | CN | claimed |
| CN-115873155-A | External electron donor composition, propylene polymerization catalytic composition and propylene polymerization method | 湖北华邦化学有限公司 | 2023-03-31 | — | — | CN | claimed |
| CN-105524192-B | Polypropylene catalyst composition with high temperature active inhibitory action and application thereof | 大唐国际化工技术研究院有限公司 | 2017-11-14 | — | — | CN | claimed |
| EP-4508101-B1 | PROCESS FOR MANUFACTURING OF POLYISOBUTENE SUCCINIC ANHYDRIDES | BASF SE (DE) | 2026-03-25 | — | — | EP | disclosed |
| EP-4709518-A1 | PROCESS FOR THE PREPARATION OF POLYISOBUTENE FROM OLEFINS FROM ISOBUTANOL OBTAINED FROM MIXED GUERBET REACTION OF ETHANOL AND METHANOL | BASF SE (DE) | 2026-03-18 | — | — | EP | disclosed |
| EP-4667447-A1 | PROCESS FOR THE PREPARATION OF POLYISOBUTENE FROM BIO-BASED OLEFINS FROM PRIMARY ALCOHOL | BASF SE (DE) | 2025-12-24 | — | — | EP | disclosed |
| US-20250250382-A1 | PROCESS FOR MANUFACTURING OF POLYISOBUTENE SUCCINIC ANHYDRIDES | BASF SE (DE) | 2025-08-07 | — | — | US | disclosed |
| US-20250250403-A1 | PROCESS FOR MANUFACTURING OF POLYISOBUTENE SUCCINIC ANHYDRIDES | BASF SE (DE) | 2025-08-07 | — | — | US | disclosed |
| US-20250179224-A1 | MEDIUM MOLECULAR POLYISOBUTENE WITH A CERTAIN DISTRIBUTION OF DOUBLE BOND ISOMERS | BASF SE (DE) | 2025-06-05 | — | — | US | disclosed |
| EP-2217564-A1 | COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE | XenoPort, Inc. (US) | 2010-08-18 | — | — | EP | disclosed |
| US-20100120740-A1 | PRODRUGS OF FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE | SEPRACOR INC. (US) | 2010-05-13 | — | — | US | disclosed |
| US-20100120740-A1 | PRODRUGS OF FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE | SEPRACOR INC. (US) | 2010-05-13 | — | — | US | disclosed |
| US-7666572-B2 | Resist top coat composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2010-02-23 | — | — | US | disclosed |
| US-20090076147-A1 | COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE | XENOPORT, INC. | 2009-03-19 | — | — | US | disclosed |
| WO-2009033054-A1 | COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE | XENOPORT, INC. (US) | 2009-03-12 | — | — | WO | disclosed |
| EP-0360497-A2 | Olefin polymerization catalyst, component thereof and process for polymerizing olefins with the catalyst, the film and injection-molded article from the obtained polyolefin | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1990-03-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090076147-A1 | COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE | ADSL, SLC19A1, SLC25A21 | ADRB2 4511/4885ADRB1 4361/4885ADRB3 4322/4885 |
| US-20100120740-A1 | PRODRUGS OF FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE | DDO, DAO, AOC1 | ADRB2 1764/4885ADRB1 1305/4885ADRB3 1718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.